HOME >> MEDICINE >> NEWS
Moderate alcohol intake may reduce risk of dementia in older women

of blood clots and increase blood flow, thereby improving cognition."

Espeland said alcohol also tends to increase levels of high-density lipoprotein, or "good" cholesterol, which might also reduce the risk for narrowed vessels in the brain. In addition, alcohol may decrease the formation of plaque that is associated with Alzheimer's disease.

Previous studies have also indicated that moderate levels of alcohol intake reduce the risk of dementia and decline in cognitive function. Espeland said, however, that the results must be interpreted with caution.

"While evidence is growing that alcohol is beneficial in this area, it is still unclear whether alcohol intake or another defining characteristic is the reason for reduced risk," he said.

The researchers adjusted for other factors that might affect the results, such as education level and family income, and still found the same pattern of moderate alcohol intake associated with better cognitive function and less risk of dementia.

"But we cannot rule out that unmeasured factors affected cognition," he said. "My sense is that for older women who choose to drink and are not restricted from drinking for medical reasons moderate alcohol intake is not harmful for cognition and may provide some benefits by reducing the risk of cognitive decline.

"Until we better understand the reasons why alcohol consumption is associated with better cognitive functioning, however, these results on their own are not a reason for people who don't drink to start or for those who drink less to increase their intake."

Espeland's co-researchers were Lin Gu, M.S., Laura Coker, Ph.D., and Stephen R. Rapp, Ph.D., also from Wake Forest Baptist, Kamal H. Masaki, M.D., from the University of Hawaii, Robert D. Langer, M.D., M.P.H., from the University of California at San Diego School of Medicine, Marcia L. Stefanick, Ph.D., from Stanford University School of Medicine, and Judith Ockene, Ph.D.
'"/>

Contact: Karen Richardson
krchrdsn@wfubmc.edu
336-716-4453
Wake Forest University Baptist Medical Center
21-Jan-2005


Page: 1 2 3

Related medicine news :

1. Moderate exercise and simple dietary supplements significantly reduce risk of atherosclerosis
2. Moderate amounts of alcohol may help prevent death from CVD in men with hypertension
3. Moderate-fat diet is kinder to heart than low-fat diet, study by UB researcher shows
4. Moderate alcohol use may be associated with brain shrinkage
5. Moderate alcohol consumption linked to brain shrinkage
6. Moderate physical activity is critical for reducing the risk of chronic disease in older women
7. Moderately high homocysteine tied to stroke, Alzheimers risk
8. Moderate alcohol consumption reduces cardiovascular risk in postmenopausal women
9. Moderate levels of worry can motivate women to get mammograms
10. College alcohol problems exceed previous estimates
11. Genes for alcohol consumption identified

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Moderate alcohol intake may reduce risk dementia older women

(Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... published today in PLOS Pathogens , children who ... common can mount an immune response to infection with ... bouts of high fever and illness and partially control ... findings may help researchers develop future interventions that prevent ... , Each year, approximately 200 million cases of malaria ...
(Date:4/17/2014)... Two recent papers by a University of ... help scientists develop treatments or vaccines for Dengue ... and other disease-causing flaviviruses. , Jeffrey S. Kieft, ... at the School of Medicine and an early ... and colleagues recently published articles in the scholarly ...
(Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
(Date:1/14/2014)... Jan. 14, 2014 Animal Emergency Critical Care, a LifeCentre partner ... Virginia is the first in Loudoun County ... Dr. Susan M. Barnes , Medical Director, is ... husband, Dr. Cole Taylor , are avid scuba divers. "As ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2
Cached News: